Please login to the form below

Not currently logged in
Email:
Password:

IPG Mediabrands creates healthcare agency

New global life sciences division Healix launched in the US

IPG MediabrandsInternational media agency group IPG Mediabrands has launched a new healthcare offering focused exclusively on life science and healthcare brands.

Based in New York with affiliates across the EMEA and Asia-Pacific regions, the new agency - called Healix - will provide pharmaceutical, biotech and healthcare clients with media planning strategies created using innovative data analytics tools.

Henry Tajer, global chief executive of IPG Mediabrands, said: “Healix is an evolution of our best-in-class services.

“The dynamic talent working at Healix is wholly committed to creating better business outcomes for healthcare brands, backed by our network's expertise across media intelligence and innovation.”

Jeffrey Erb will lead the new venture as president of its North American operations, joining the agency group from Alliance Life Sciences where he served as its senior vice president and managing director.

Erb commented: “I'm very excited to be part of the IPG Mediabrands team and its innovative approach to media.

“The creation of a media company completely dedicated to healthcare demonstrates IPG Mediabrands' commitment to providing its clients with the highest caliber of service specific to their market.

“I'm thrilled to be leading that charge.”

Article by
Rebecca Clifford

10th October 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...

Infographics